RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer

      한글로보기

      https://www.riss.kr/link?id=A105893218

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Use of radiotherapy combined with chemotherapy is increasing in hypopharyngeal cancer. However, many show residual tumor after radiotherapy. Timing for treatment evaluation and salvage therapy is essential. However, optimal timing for salvage surgery has not been suggested. In this study, we tried to evaluate optimal timing for salvage surgery.
      Methods and Materials: Patients who were diagnosed with hypopharyngeal squamous cell carcinoma between 2006 and 2015 were retrospectively analyzed. All patients received definitive radiotherapy with or without chemotherapy. Response of all treated patients were analyzed at 1, 3, and 6 months after radiotherapy. Any patients with progression before 6 months were excluded.
      Results: A total of 54 patients were analyzed. Complete remission (CR) rates at 1 month (CR1), 3 months (CR3) and 6 months (CR6) were 66.7%, 81.5%, and 90.7%, respectively. Non-CR at 1 month (NCR1), 3 months (NCR3), and 6 months (NCR6) showed poor locoregional recurrence-free survival rates (1-year rates of 63.7%, 66.7%, and 0.0%, respectively) compared to CR1, CR3, and CR6 (1- year rates 94.3%, 88.0%, and 91.5%, respectively). Particularly significant differences were seen between CR6 and NCR6 (p < 0.001).
      Of 10 patients with NCR3, 5 showed CR at 6 months (NCR3/CR6). There was no statistical difference in locoregional recurrence-free survival between CR3 and NCR3/CR6 group (p = 0.990).
      Conclusion: Our data suggest half of patients who did not show CR at 3 months eventually achieved CR at 6 months. Waiting until 6 months after radiotherapy may be appropriate for avoiding additional salvage therapy.
      번역하기

      Purpose: Use of radiotherapy combined with chemotherapy is increasing in hypopharyngeal cancer. However, many show residual tumor after radiotherapy. Timing for treatment evaluation and salvage therapy is essential. However, optimal timing for salvage...

      Purpose: Use of radiotherapy combined with chemotherapy is increasing in hypopharyngeal cancer. However, many show residual tumor after radiotherapy. Timing for treatment evaluation and salvage therapy is essential. However, optimal timing for salvage surgery has not been suggested. In this study, we tried to evaluate optimal timing for salvage surgery.
      Methods and Materials: Patients who were diagnosed with hypopharyngeal squamous cell carcinoma between 2006 and 2015 were retrospectively analyzed. All patients received definitive radiotherapy with or without chemotherapy. Response of all treated patients were analyzed at 1, 3, and 6 months after radiotherapy. Any patients with progression before 6 months were excluded.
      Results: A total of 54 patients were analyzed. Complete remission (CR) rates at 1 month (CR1), 3 months (CR3) and 6 months (CR6) were 66.7%, 81.5%, and 90.7%, respectively. Non-CR at 1 month (NCR1), 3 months (NCR3), and 6 months (NCR6) showed poor locoregional recurrence-free survival rates (1-year rates of 63.7%, 66.7%, and 0.0%, respectively) compared to CR1, CR3, and CR6 (1- year rates 94.3%, 88.0%, and 91.5%, respectively). Particularly significant differences were seen between CR6 and NCR6 (p < 0.001).
      Of 10 patients with NCR3, 5 showed CR at 6 months (NCR3/CR6). There was no statistical difference in locoregional recurrence-free survival between CR3 and NCR3/CR6 group (p = 0.990).
      Conclusion: Our data suggest half of patients who did not show CR at 3 months eventually achieved CR at 6 months. Waiting until 6 months after radiotherapy may be appropriate for avoiding additional salvage therapy.

      더보기

      참고문헌 (Reference)

      1 Huang SH, "Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status" 87 : 1078-1085, 2013

      2 Newman JR, "Survival trends in hypopharyngeal cancer: a population-based review" 125 : 624-629, 2015

      3 Taki S, "Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients" 267 : 1765-1769, 2010

      4 Stoeckli SJ, "Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx" 126 : 1473-1477, 2000

      5 Wong LY, "Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery" 25 : 953-959, 2003

      6 Kapoor V, "Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging" 184 : 579-587, 2005

      7 Hanna E, "Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation" 130 : 875-879, 2004

      8 Wang YF, "Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy" 31 : 442-451, 2009

      9 Mehanna H, "PET-CT surveillance versus neck dissection in advanced head and neck cancer" 374 : 1444-1454, 2016

      10 Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)" 45 : 228-247, 2009

      1 Huang SH, "Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status" 87 : 1078-1085, 2013

      2 Newman JR, "Survival trends in hypopharyngeal cancer: a population-based review" 125 : 624-629, 2015

      3 Taki S, "Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients" 267 : 1765-1769, 2010

      4 Stoeckli SJ, "Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx" 126 : 1473-1477, 2000

      5 Wong LY, "Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery" 25 : 953-959, 2003

      6 Kapoor V, "Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging" 184 : 579-587, 2005

      7 Hanna E, "Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation" 130 : 875-879, 2004

      8 Wang YF, "Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy" 31 : 442-451, 2009

      9 Mehanna H, "PET-CT surveillance versus neck dissection in advanced head and neck cancer" 374 : 1444-1454, 2016

      10 Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)" 45 : 228-247, 2009

      11 Pignon JP, "Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients" 92 : 4-14, 2009

      12 Boscolo-Rizzo P, "Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation" 118 : 300-306, 2008

      13 Lefebvre JL, "Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891" 23 : 2708-2714, 2012

      14 Department of Veterans Affairs Laryngeal Cancer Study Group, "Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer" 324 : 1685-1690, 1991

      15 Silver CE, "Current trends in initial management of laryngeal cancer: the declining use of open surgery" 266 : 1333-1352, 2009

      16 Takes RP, "Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery" 34 : 270-281, 2012

      17 Zundel MT, "Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer" 81 : e825-e832, 2011

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 선정 (해외등재 학술지 평가) KCI등재
      2020-12-01 평가 등재후보로 하락 (해외등재 학술지 평가) KCI등재후보
      2015-01-01 평가 SCOPUS 등재 (기타) KCI등재
      2013-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2012-04-01 평가 등재후보로 하락 (기타) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-12-30 학회명변경 영문명 : The Korean Society For Therapeutic Radiology And Oncology -> The Korean Society for Radiation Oncology KCI등재
      2011-08-22 학술지명변경 한글명 : 대한방사선종양학회지 -> Radiation oncology journal
      외국어명 : The Journal of the Korean Society for Therapeutic Radiology and Oncology -> Radiation oncology journal
      KCI등재
      2009-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.31 0.31 0.25
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.864 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼